A Clinical Study Investigating the Comparability of Somatrogon in Two Different Drug Product Presentations
Status:
Completed
Trial end date:
2019-04-19
Target enrollment:
Participant gender:
Summary
This is a Phase 1, single-center, open-label randomized, 2×2 crossover (Ref Test | Test Ref)
study with a washout of two weeks to establish bioequivalence between single dose of
somatrogon in a PEN to somatrogon in VIAL administered sc in healthy male volunteers.